D J Duncker, P D Verdouw. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh： See more » 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitorsAdrenergic beta-Antagonists/pharmacologyAdrenergic beta-Antagonists/therapeutic useAnimalsCalcium Channel Agonists/pharmacologyCalcium Channel Agonists/therapeutic useCardiotonic Agents/pharmacologyCardiotonic Agents/therapeutic useCyclic Nucleotide Phosphodiesterases, Type 3Energy Metabolism/drug effectsHeart Failure/drug therapyHemodynamics/drug effectsHumansPhosphodiesterase Inhibitors/pharmacologyPhosphodiesterase Inhibitors/therapeutic usePyridazines/pharmacologyPyridazines/therapeutic useSwine
Substances： See more » Adrenergic beta-AntagonistsCalcium Channel AgonistsCardiotonic AgentsPhosphodiesterase InhibitorsPyridazinesMCI 1543',5'-Cyclic-AMP PhosphodiesterasesCyclic Nucleotide Phosphodiesterases, Type 3
Year: 2002 PMID： 12079634
Source DB: PubMed Journal: Scand Cardiovasc J ISSN： 1401-7431 Impact factor: 1.589